These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 8549329

  • 21. Induction of resistance of Streptococcus pneumoniae to quinolones in vitro.
    Lafredo SC, Foleno BD, Fu KP.
    Chemotherapy; 1993; 39(1):36-9. PubMed ID: 8383031
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. In vitro activity of sparfloxacin (CI-978), a new broad-spectrum fluoroquinolone.
    Qadri SM, Ueno Y, Burns JJ, Almodovar E, Rabea N.
    Chemotherapy; 1992; 38(2):99-106. PubMed ID: 1317282
    [Abstract] [Full Text] [Related]

  • 27. A multicenter study on the comparative in vitro activity of fleroxacin and three other quinolones: an interim report from 27 centers.
    Beskid G, Prosser BL.
    Am J Med; 1993 Mar 22; 94(3A):2S-8S. PubMed ID: 8383919
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. ESGAB breakpoint determination: temafloxacin.
    Phillips I, Acar J, Baquero F, Bergan T, Forsgren A, Wiedemann B.
    Eur J Clin Microbiol Infect Dis; 1991 Nov 22; 10(11):991-2. PubMed ID: 1665417
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Bactericidal action of lomefloxacin a new pyridonecarboxylic acid derivative].
    Koikeda S, Okabe H, Shibata H, Hase T, Nakanishi N, Okezaki E, Kato H, Masamune Y.
    Jpn J Antibiot; 1989 Jan 22; 42(1):193-9. PubMed ID: 2468799
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Absence of bactericidal activity of sparfloxacin and ciprofloxacin under anaerobic conditions.
    Morrissey I, Smith JT.
    J Antimicrob Chemother; 1992 May 22; 29(5):589-90. PubMed ID: 1320605
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. In vitro susceptibility of anaerobic bacteria to temafloxacin.
    Southern PM, Patel S.
    Clin Infect Dis; 1993 Jun 22; 16 Suppl 4():S334. PubMed ID: 8391861
    [No Abstract] [Full Text] [Related]

  • 39. In vitro susceptibility testing of BMS-284756 by the BSAC standardized disc testing method.
    Andrews JM, Wise R.
    J Antimicrob Chemother; 2001 Aug 22; 48(2):322-4. PubMed ID: 11481314
    [No Abstract] [Full Text] [Related]

  • 40. Antimicrobial activity, pharmacokinetics and clinical studies of balofloxacin (Q-35) in obstetrics and gynaecology.
    Cho N, Miyakawa Z, Kimura T, Shimizu A, Notake Y, Kunii K.
    Drugs; 1995 Aug 22; 49 Suppl 2():391-2. PubMed ID: 8549373
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.